-
An Exploration of the Incidence Rate of Anxiety and Depression Following a Diagnosis of Osteoarthritis Using the THIN Dataset
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Economic Burden of COPD in Algeria: A Retrospective Analysis of Healthcare Resource Utilization and Costs
Sep 9, 2025, 16:22 PM -
Environmental Impact of Intravenous vs. Oral Chemotherapy in France: A 1000-Patient Model-Based Assessment
Sep 9, 2025, 16:22 PM -
Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches
Sep 9, 2025, 16:22 PM -
Investigation of Patient Satisfaction With Home Nursing Care Among Recipients
Sep 9, 2025, 16:22 PM -
Balancing Power and Interpretation: Responder Analysis vs. Mean Differences for PRO Endpoints in Oncology Clinical Trials
Sep 9, 2025, 16:22 PM -
Who Speaks For Europe? A Country-Level Analysis Of Representation And Expertise In EU Health Technology Assessment Joint Bodies
Sep 9, 2025, 16:22 PM -
Treatment Effect Extrapolation Assumptions in NICE Highly Specialized Technology Appraisals
Sep 9, 2025, 16:22 PM -
Expanded Access to Oncology Therapies in Mexico: The Role of Bioequivalent Abiraterone and Axitinib
Sep 9, 2025, 16:22 PM -
Impact of Individualized Neoantigen Therapies on Health, Productivity, and Health System Capacity Outcomes in Resected Melanoma in Belgium
Sep 9, 2025, 16:22 PM -
Hospital Mortality in Germany Analysis of German Hospital Data From 2000 to 2019
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
Measuring the Disease Burden and Quality of Life From the Schizophrenia Caregivers’ Perspective
Sep 9, 2025, 16:22 PM -
Identifying CKD As a Key Driver of CVD Deaths
Sep 9, 2025, 16:22 PM -
All-Cause Healthcare Resource Use in Recurrent Respiratory Papillomatosis: A Claims-Based Comparison With Matched Controls
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Impacts of Living With Primary Lateral Sclerosis (PLS): The Development of a Conceptual Model
Sep 9, 2025, 16:22 PM -
Flexible Parametric Inference for Cause-Specific Hazard-Competing Risk Models Under Interval Censoring
Sep 9, 2025, 16:22 PM -
HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?
Sep 9, 2025, 16:22 PM
